Wealth Enhancement Advisory Services’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
PGCM
Wealth Enhancement Advisory Services's HCAT Position: Q3 2026 in Review
Wealth Enhancement Advisory Services sold out of Health Catalyst (HCAT) in Q3 2026, closing a stake of 11,073 shares — an estimated $25.4K sold.
Wealth Enhancement Advisory Services first reported a position in HCAT in Q3 2025 and held it in 3 quarters. The position peaked at $392K in Q3 2025. 48 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.
- Wealth Enhancement Advisory Services reported no remaining Health Catalyst position as of Q3 2026 after selling out during the quarter.
- Wealth Enhancement Advisory Services sold 11,073 Health Catalyst shares in Q3 2026, an estimated $25.4K.
- Wealth Enhancement Advisory Services first reported a position in Health Catalyst in Q3 2025 and held it in 3 quarters.
- Wealth Enhancement Advisory Services's Health Catalyst position peaked at $392K in Q3 2025.
- 48 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.